TABLE 3.
Univariate analysis | Multi‐variate analysis | |||||||
---|---|---|---|---|---|---|---|---|
B | SE | Wald | df | p | Exp (B) | p | Exp (B) | |
General parameters | ||||||||
Age | 0.025 | 0.008 | 9.722 | 1.000 | 0.002** | 1.025 | 0.029* | 1.020 |
BMI | −0.045 | 0.021 | 4.494 | 1.000 | 0.032* | 0.956 | 0.079 | 0.963 |
ECOG | 0.044 | 1.000 | 0.934 | 0.860 | ||||
ISUP Group | 0.162 | 0.066 | 5.928 | 1.000 | 0.013* | 1.176 | 0.012* | 1.183 |
DeNovo Mets | −0.085 | 0.165 | 0.266 | 1.000 | 0.606 | 0.919 | ||
1st ARAT agent | 0.269 | 0.139 | 3.716 | 1.000 | 0.054 | 1.308 | ||
Pre‐ or post‐chemotherapy ARAT | ||||||||
Duration from HSPC to CRPC | 0.000 | 0.000 | 2.671 | 1.000 | 0.102 | 1.000 | ||
Serum markers | ||||||||
iPSA | 0.000 | 0.000 | 0.309 | 1.000 | 0.578 | 1.000 | ||
Nadir PSA during ADT | 0.005 | 0.001 | 18.221 | 1.000 | 0.00002** | 1.005 | 0.00009** | 1.005 |
PSA when starting ARAT | 0.000 | 0.000 | 0.219 | 1.000 | 0.640 | 1.000 |
Abbreviations: ADT = androgen deprivation therapy; ARAT = androgen receptor‐axis‐targeted therapies; BMI = Body Mass Index; ECOG = Eastern Cooperative Oncology Group; ISUP = International Society of Urological Pathology; PSA = prostate‐specific antigen.
p < 0.05.
p < 0.01.